Inverse association between duration of use of acid-suppressive medications and fracture risk

Archives of Internal Medicine

Volumn 171, Issue 11, 2011, Pages 1044-

  de Vries, Frank ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

CORRELATION ANALYSIS; DRUG USE; FRACTURE; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 79959321503     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.226     Document Type: Letter

References (2)

1. Abrahamsen B, Eiken P, Eastell R. Proton pump inhibitor use and the anti-fracture efficacy of alendronate [published online February 14, 2011]. Arch Intern Med. 2011;171(11):998-1004.
2. de Vries F, Cooper AL, Cockle SM, van Staa TP, Cooper C. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. 2009;20(12):1989-1998.